Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · March 10, 2023

Safety and Efficacy of Intensive LDL-C Lowering to Very Low Levels

European Heart Journal: Cardiovascular Pharmacotherapy


Additional Info

European Heart Journal: Cardiovascular Pharmacotherapy
Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials
Eur Heart J Cardiovasc Pharmacother 2023 Feb 02;9(2)138-147, G Patti, EG Spinoni, L Grisafi, R Mehran, M Mennuni

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading